Thrombotic microangiopathy associated with lenvatinib therapy

SUMMARY: Systemic thrombotic microangiopathy (TMA) is a serious condition whose early treatment is essential to reduce morbidity and mortality. TMA with only renal involvement has been associated with tyrosine kinase inhibitors, including lenvatinib, a drug used for certain advanced neoplasms. To da...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras Angulo, Macarena, García Izquierdo, Belén, Armengod Grao, Laura, Palacios García, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305564/
https://www.ncbi.nlm.nih.gov/pubmed/37434645
http://dx.doi.org/10.1530/EO-22-0078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305564/
https://www.ncbi.nlm.nih.gov/pubmed/37434645
http://dx.doi.org/10.1530/EO-22-0078

Ejemplares similares